Momentum Acetabular Cup System
United Orthopedic Corporation · Decision date Sep 2, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision for the Momentum Acetabular Cup System, application K253948, on September 2, 2026, under 21 CFR 888.3353 with product codes LZO, OQI, MEH and LPH. The applicant is United Orthopedic Corporation. The submission is a Traditional 510(k), so this decision is a clearance rather than a PMA approval. The summary lists K170359 Trinity Dual Mobility System as the primary predicate, with additional predicates including K150522, K190660 and K221149.
The cleared system covers six components: the Momentum Acetabular Shell PS+, XPE and E-XPE liners, a Co-Cr-Mo dual mobility metal liner, an E-XPE mobile bearing, and UHMWPE screw hole covers. The summary states cementless, single-use use in total hip arthroplasty for primary and revision indications, and describes materials, sizes and sterilization as the same as or similar to the predicates. The FDA page lists a received date of 12/10/2025, which differs from the August 4, 2026 date in the letter; the reason for the discrepancy is not stated in the available text.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K253948
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- United Orthopedic Corporation
- Product code
- LZO
- Decision code
- SESE
- Decision date
- Sep 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented.
- Applicant
- United Orthopedic Corporation
- Product code
- LZO
- FDA device class
- 2
FDA decision timeline
K253948 received
Application receipt date recorded by FDA.
K253948 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LZO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
NEXUS Hip StemK262473 | Microport Orthopedics, Inc. | 510(k) clearance | Oct 1, 2026 | FDA |
| Medacta International S.A. | 510(k) clearance | Sep 17, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
United Orthopedic Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Kaohsiung City
Sources and methodology
- Original FDA record: K253948
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
